Atreca Inc Stock Piotroski F Score
BCEL Stock | USD 0.26 0.03 13.04% |
Atreca | Piotroski F Score |
At this time, it appears that Atreca's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
1 | Current Return On Assets | Negative | Focus |
2 | Change in Return on Assets | Decreased | Focus |
3 | Cash Flow Return on Assets | Negative | Focus |
4 | Current Quality of Earnings (accrual) | Improving | Focus |
5 | Asset Turnover Growth | N/A | Focus |
6 | Current Ratio Change | Increase | Focus |
7 | Long Term Debt Over Assets Change | Higher Leverage | Focus |
8 | Change In Outstending Shares | Decrease | Focus |
9 | Change in Gross Margin | N/A | Focus |
Atreca Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Atreca is to make sure Atreca is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Atreca's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Atreca's financial numbers are properly reported.
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Weighted Average Shares Diluted | 33.6 M | 38.6 M |
|
| |||||
Weighted Average Shares | 33.6 M | 38.6 M |
|
| |||||
Current Liabilities | 14.9 M | 16.3 M |
|
| |||||
Total Liabilities | 82.7 M | 76.6 M |
|
| |||||
Total Debt | 79.3 M | 73.5 M |
|
| |||||
Current Assets | 115.8 M | 78 M |
|
| |||||
Total Assets | 176.2 M | 155 M |
|
|
Atreca Inc F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Atreca's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Atreca in a much-optimized way.
Click cells to compare fundamentals
About Atreca Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value per Share |
|
About Atreca Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atreca Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atreca using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atreca Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atreca in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atreca's short interest history, or implied volatility extrapolated from Atreca options trading.
Pair Trading with Atreca
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atreca position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will appreciate offsetting losses from the drop in the long position's value.Moving together with Atreca Stock
+ | 0.63 | JNJ | Johnson Johnson | Fiscal Quarter End 31st of December 2023 | PairCorr | |
+ | 0.67 | MRK | Merck Company | Fiscal Quarter End 31st of December 2023 | PairCorr | |
+ | 0.69 | PFE | Pfizer Inc | Fiscal Quarter End 31st of December 2023 | PairCorr | |
+ | 0.67 | IPHA | Innate Pharma | Financial Report 28th of March 2024 | PairCorr |
Moving against Atreca Stock
- | 0.46 | SIRI | Sirius XM Holding | Buyout Trend | PairCorr | |
- | 0.46 | PLTR | Palantir TechnologiesInc | Fiscal Quarter End 31st of December 2023 | PairCorr |
The ability to find closely correlated positions to Atreca could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atreca when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atreca - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atreca Inc to buy it.
The correlation of Atreca is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atreca moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atreca Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atreca can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Atreca Altman Z Score, Atreca Correlation, Atreca Valuation, as well as analyze Atreca Alpha and Beta and Atreca Hype Analysis. Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Atreca Stock analysis
When running Atreca's price analysis, check to measure Atreca's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atreca is operating at the current time. Most of Atreca's value examination focuses on studying past and present price action to predict the probability of Atreca's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atreca's price. Additionally, you may evaluate how the addition of Atreca to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Atreca's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atreca. If investors know Atreca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atreca listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.50) | Return On Assets (0.51) | Return On Equity (1.83) |
The market value of Atreca Inc is measured differently than its book value, which is the value of Atreca that is recorded on the company's balance sheet. Investors also form their own opinion of Atreca's value that differs from its market value or its book value, called intrinsic value, which is Atreca's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atreca's market value can be influenced by many factors that don't directly affect Atreca's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atreca's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atreca is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atreca's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.